In vivo model to study the biocompatibility of peritoneal dialysis solutions. 1997

K Wieczorowska-Tobis, and K Korybalska, and A Polubinska, and M Radkowski, and A Breborowicz, and D G Oreopoulos
Department of Pathophysiology, University Medical School, Poznan, Poland.

This study was designed to analyze the complex morphologic and functional effects of dialysis solutions on peritoneum in a rat model on chronic peritoneal dialysis. Peritoneal catheters were inserted into 10 male, Wistar rats and the animals were dialyzed twice daily for 4 weeks with 4.25% Dianeal. During the study we observed two opposite effects: healing of the peritoneum after catheter implantation--decreased cell count in dialysate, decreased permeability of the peritoneum to glucose and total protein, increased volume of drained dialysate; and damage to the membrane due to its exposure to peritoneal dialysis solution--increased hyaluronic acid levels in dialysate, a tendency of the peritoneum to thicken when compared to non-dialyzed animals. Our rat model of CAPD may be used for quantitative and qualitative assessment of the effects of peritoneal dialysis solution on the peritoneum during chronic dialysis.

UI MeSH Term Description Entries
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D008297 Male Males
D010531 Peritoneal Dialysis, Continuous Ambulatory Portable peritoneal dialysis using the continuous (24 hours a day, 7 days a week) presence of peritoneal dialysis solution in the peritoneal cavity except for periods of drainage and instillation of fresh solution. CAPD,Continuous Ambulatory Peritoneal Dialysis
D010537 Peritoneum A membrane of squamous EPITHELIAL CELLS, the mesothelial cells, covered by apical MICROVILLI that allow rapid absorption of fluid and particles in the PERITONEAL CAVITY. The peritoneum is divided into parietal and visceral components. The parietal peritoneum covers the inside of the ABDOMINAL WALL. The visceral peritoneum covers the intraperitoneal organs. The double-layered peritoneum forms the MESENTERY that suspends these organs from the abdominal wall. Parietal Peritoneum,Peritoneum, Parietal,Peritoneum, Visceral,Visceral Peritoneum,Parametrium,Parametriums
D011506 Proteins Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. Gene Products, Protein,Gene Proteins,Protein,Protein Gene Products,Proteins, Gene
D002404 Catheterization Use or insertion of a tubular device into a duct, blood vessel, hollow organ, or body cavity for injecting or withdrawing fluids for diagnostic or therapeutic purposes. It differs from INTUBATION in that the tube here is used to restore or maintain patency in obstructions. Cannulation,Cannulations,Catheterizations
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D006820 Hyaluronic Acid A natural high-viscosity mucopolysaccharide with alternating beta (1-3) glucuronide and beta (1-4) glucosaminidic bonds. It is found in the UMBILICAL CORD, in VITREOUS BODY and in SYNOVIAL FLUID. A high urinary level is found in PROGERIA. Amo Vitrax,Amvisc,Biolon,Etamucine,Healon,Hyaluronan,Hyaluronate Sodium,Hyvisc,Luronit,Sodium Hyaluronate,Acid, Hyaluronic,Hyaluronate, Sodium,Vitrax, Amo
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014508 Urea A compound formed in the liver from ammonia produced by the deamination of amino acids. It is the principal end product of protein catabolism and constitutes about one half of the total urinary solids. Basodexan,Carbamide,Carmol

Related Publications

K Wieczorowska-Tobis, and K Korybalska, and A Polubinska, and M Radkowski, and A Breborowicz, and D G Oreopoulos
May 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation,
K Wieczorowska-Tobis, and K Korybalska, and A Polubinska, and M Radkowski, and A Breborowicz, and D G Oreopoulos
January 1993, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis,
K Wieczorowska-Tobis, and K Korybalska, and A Polubinska, and M Radkowski, and A Breborowicz, and D G Oreopoulos
January 1993, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis,
K Wieczorowska-Tobis, and K Korybalska, and A Polubinska, and M Radkowski, and A Breborowicz, and D G Oreopoulos
January 1993, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis,
K Wieczorowska-Tobis, and K Korybalska, and A Polubinska, and M Radkowski, and A Breborowicz, and D G Oreopoulos
March 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
K Wieczorowska-Tobis, and K Korybalska, and A Polubinska, and M Radkowski, and A Breborowicz, and D G Oreopoulos
October 1996, Advances in renal replacement therapy,
K Wieczorowska-Tobis, and K Korybalska, and A Polubinska, and M Radkowski, and A Breborowicz, and D G Oreopoulos
January 2000, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis,
K Wieczorowska-Tobis, and K Korybalska, and A Polubinska, and M Radkowski, and A Breborowicz, and D G Oreopoulos
January 2000, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis,
K Wieczorowska-Tobis, and K Korybalska, and A Polubinska, and M Radkowski, and A Breborowicz, and D G Oreopoulos
January 1995, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis,
K Wieczorowska-Tobis, and K Korybalska, and A Polubinska, and M Radkowski, and A Breborowicz, and D G Oreopoulos
January 1997, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis,
Copied contents to your clipboard!